Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 91: Which one of the following drugs does not undergo the hepatic first-pass effect?

A. Propranolol
B. Lidocaine
C. Insulin (Correct Answer)
D. Morphine

Explanation: ### Explanation **Concept: Hepatic First-Pass Effect** The hepatic first-pass effect (presystemic metabolism) occurs when a drug is metabolized by the liver or gut wall before it reaches the systemic circulation. This phenomenon is primarily associated with drugs administered **orally**, as they are absorbed from the gastrointestinal tract into the portal venous system. **Why Insulin is the Correct Answer:** Insulin is a polypeptide hormone. If administered orally, it would be degraded by gastrointestinal proteolytic enzymes (like pepsin and trypsin) and would not survive to reach the portal circulation for "first-pass" metabolism. Therefore, insulin is administered **parenterally** (subcutaneously or intravenously), bypassing the entire enteral absorption route and the hepatic first-pass effect. **Analysis of Incorrect Options:** * **Propranolol:** A classic example of a drug with a very high first-pass metabolism (~75%). This is why the oral dose is significantly higher than the intravenous dose. * **Lidocaine:** It undergoes extensive first-pass metabolism, making it ineffective when given orally for cardiac arrhythmias; hence, it is administered intravenously. * **Morphine:** It undergoes significant glucuronidation in the liver during its first pass, leading to a much lower oral bioavailability compared to parenteral administration. **High-Yield Clinical Pearls for NEET-PG:** * **Routes bypassing first-pass:** Sublingual (e.g., Nitroglycerin), Transdermal, Rectal (partial bypass), and all Parenteral routes (IV, IM, SC). * **High First-Pass Drugs (Mnemonic: "LMP"):** **L**idocaine, **M**orphine, **P**ropranolol, along with Nitroglycerin, Salbutamol, and Verapamil. * **Bioavailability ($F$):** Drugs with high first-pass metabolism have low oral bioavailability. $F = 1 - ER$ (where $ER$ is the Extraction Ratio).

Question 92: Therapeutic Drug Monitoring (TDM) involves measurement of plasma concentrations of drugs to determine if the drug levels are within the therapeutic range. For TDM to be clinically useful, what criteria should be fulfilled?

A. There should be a good relationship between plasma concentration and drug dosage.
B. The relationship between plasma drug concentration and therapeutic response and/or toxicity should be poor.
C. When pharmacodynamic tolerance is suspected.
D. When the clinical response cannot be easily monitored. (Correct Answer)

Explanation: **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in plasma to optimize a patient’s drug regimen. The fundamental principle of TDM is that for certain drugs, the **plasma concentration correlates better with the clinical effect (efficacy or toxicity) than the administered dose.** **Why Option D is Correct:** TDM is most clinically useful when the **clinical response is difficult to measure or monitor directly.** For example, with anticonvulsants (like Phenytoin), one cannot wait for a seizure to occur to know if the dose is adequate. Similarly, with Lithium or Digoxin, the signs of toxicity can be subtle or delayed. In such cases, plasma levels serve as a surrogate marker for efficacy and safety. **Analysis of Incorrect Options:** * **Option A:** If there were a perfect, predictable relationship between dosage and plasma concentration, TDM would be unnecessary; one could simply adjust the dose based on a formula. TDM is needed specifically when this relationship is **unpredictable** (e.g., due to individual variations in metabolism). * **Option B:** For TDM to be valid, there must be a **strong (not poor) correlation** between plasma concentration and the pharmacological effect. If this relationship is poor, the plasma level tells us nothing about the patient's clinical status. * **Option C:** In cases of **pharmacodynamic tolerance**, the body’s sensitivity to the drug changes at the receptor level. Even if plasma levels are within the "normal" range, the drug may not work, making TDM misleading rather than helpful. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Drugs with a **Narrow Therapeutic Index** (e.g., Lithium, Digoxin, Aminoglycosides, Theophylline, Tricyclic Antidepressants, and Immunosuppressants like Cyclosporine). * **TDM is NOT useful for:** Drugs with "hit and run" effects (e.g., Omeprazole, MAO inhibitors) or drugs whose effects are easily measured (e.g., BP for antihypertensives, INR for Warfarin, Blood sugar for Insulin). * **Sampling Time:** Usually done at **"Steady State"** (after 4-5 half-lives) and typically measured as **trough levels** (just before the next dose).

Question 93: On administration of local anesthetic in an area of infection, it is not effective because of an increase in which of the following?

A. Cations (Correct Answer)
B. Free base
C. Uncharged base
D. None of the above

Explanation: **Explanation:** Local anesthetics (LAs) are **weak bases** that exist in an equilibrium between two forms: the **uncharged (lipid-soluble) free base** and the **charged (water-soluble) cationic form**. **1. Why Cations is the correct answer:** For a local anesthetic to work, the uncharged base must first cross the lipid-rich neuronal membrane. Once inside the cell, it re-equilibrates into the **cationic form**, which is the active moiety that binds to and blocks the voltage-gated sodium channels. In an area of **infection/inflammation**, the tissue pH drops (becomes acidic). According to the Henderson-Hasselbalch equation, an acidic environment shifts the equilibrium toward the **cationic (ionized) form**. Because these cations are charged, they cannot cross the cell membrane to reach their site of action inside the neuron. Therefore, the anesthetic effect is significantly reduced or lost. **2. Why other options are incorrect:** * **B & C (Free base / Uncharged base):** These terms are synonymous in this context. An increase in the free base would actually *improve* the drug's ability to penetrate the nerve. In acidic infected tissues, the concentration of the free base **decreases**, not increases. **Clinical Pearls for NEET-PG:** * **Active Form:** The **cation** is the active form at the receptor (inside the cell), but the **uncharged base** is required for penetration (outside the cell). * **Alkalinization:** Adding **Sodium Bicarbonate** to local anesthetics increases the pH, shifting the equilibrium toward the uncharged base. This results in a faster onset of action and reduced pain on injection. * **Lipid Solubility:** Potency of a local anesthetic is primarily determined by its lipid solubility. * **pKa:** The closer the pKa of the drug is to the physiological pH (7.4), the faster the onset of action (e.g., Lidocaine has a lower pKa than Bupivacaine).

Question 94: Which of the following drugs undergoes Hoffmann elimination?

A. d-tubocurarine
B. Acetylcholine
C. Atracurium (Correct Answer)
D. Acetazolamide

Explanation: **Explanation:** **Atracurium** is the correct answer because it is a non-depolarizing neuromuscular blocking agent that undergoes **Hoffmann elimination**. This is a unique spontaneous molecular degradation process that occurs at physiological pH and temperature, independent of renal or hepatic function. * **Mechanism:** In Hoffmann elimination, the drug molecule breaks down into inactive metabolites (primarily **laudanosine** and monoquaternary acrylate). Because it does not rely on organ-based metabolism, Atracurium (and its isomer Cisatracurium) is the drug of choice for muscle relaxation in patients with **renal or hepatic failure**. **Analysis of Incorrect Options:** * **A. d-tubocurarine:** This is a prototype non-depolarizing blocker primarily eliminated by the kidneys (unaltered) and partly by the liver. It is known for causing significant histamine release. * **B. Acetylcholine:** This neurotransmitter is rapidly hydrolyzed by the enzyme **pseudocholinesterase** (butyrylcholinesterase) in the plasma and acetylcholinesterase at the synapse, not by spontaneous degradation. * **C. Acetazolamide:** This is a carbonic anhydrase inhibitor used as a diuretic and for glaucoma. It is excreted unchanged in the urine via active tubular secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Cisatracurium:** An isomer of atracurium that also undergoes Hoffmann elimination but is more potent and produces less laudanosine, reducing the risk of seizures. * **Laudanosine Toxicity:** The major metabolite of atracurium, laudanosine, can cross the blood-brain barrier and may cause **CNS excitation or seizures** if it accumulates during prolonged infusions. * **Temperature/pH Sensitivity:** Since Hoffmann elimination is temperature and pH-dependent, the rate of drug degradation decreases in patients with **hypothermia or acidosis**, potentially prolonging the duration of neuromuscular blockade.

Question 95: Which of the following drugs can lead to failure of oral contraceptive pills (OCPs)?

A. Carbamazepine
B. Rifampicin (Correct Answer)
C. Non-steroidal anti-inflammatory drugs (NSAIDs)
D. Ethambutol

Explanation: **Explanation:** The failure of oral contraceptive pills (OCPs) is primarily caused by drugs that act as **Microsomal Enzyme Inducers**. **1. Why Rifampicin is Correct:** Rifampicin is one of the most potent inducers of the Cytochrome P450 enzyme system (specifically **CYP3A4**). OCPs contain estrogen and progesterone, which are metabolized by these liver enzymes. When Rifampicin induces these enzymes, the rate of metabolism of the hormones increases significantly, leading to sub-therapeutic plasma levels. This results in a loss of contraceptive efficacy and an increased risk of unintended pregnancy. **2. Analysis of Incorrect Options:** * **Carbamazepine:** While Carbamazepine is also an enzyme inducer and *can* cause OCP failure, **Rifampicin** is the classic and most potent example frequently tested in exams. In a single-choice question, Rifampicin is the superior answer due to its rapid and profound induction effect. * **NSAIDs:** These drugs primarily inhibit cyclooxygenase (COX) enzymes and do not significantly interfere with the hepatic metabolism of steroid hormones. * **Ethambutol:** Unlike Rifampicin, Ethambutol is an antitubercular drug that does not have enzyme-inducing properties. **3. Clinical Pearls for NEET-PG:** * **Mnemonic for Enzyme Inducers:** "GPRS Cell Phone" (**G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone). * **Antibiotic Exception:** Most routine antibiotics (like amoxicillin) do not cause OCP failure; Rifampicin is the notable exception. * **Management:** Patients on Rifampicin should be advised to use an alternative or barrier method of contraception (e.g., condoms) during treatment.

Question 96: Which of the following medications is available as a transdermal patch?

A. Flavoxate
B. Tolterodine
C. Oxybutynin (Correct Answer)
D. Aripiprazole

Explanation: **Explanation:** **Oxybutynin** is a competitive muscarinic receptor antagonist used primarily for the treatment of overactive bladder (OAB). It is available in multiple formulations, including oral (immediate and extended-release) and **transdermal patches**. The transdermal route for Oxybutynin is clinically significant because it bypasses **first-pass hepatic metabolism** (specifically the CYP3A4 enzyme in the liver and gut). This significantly reduces the formation of its active metabolite, *N-desethyloxybutynin*, which is primarily responsible for the common anticholinergic side effect of **xerostomia (dry mouth)**. Consequently, the patch offers better patient compliance compared to oral forms. **Analysis of Incorrect Options:** * **Flavoxate:** An antispasmodic used for urinary tract spasms; it is administered only **orally**. * **Tolterodine:** Another common anticholinergic for OAB. While it is available as an extended-release (ER) oral capsule, it does **not** have a transdermal patch formulation. * **Aripiprazole:** An atypical antipsychotic available as oral tablets, disintegrating tablets, and long-acting intramuscular injections, but **not** as a transdermal patch. **High-Yield Clinical Pearls for NEET-PG:** * **Common Transdermal Patches:** Remember the mnemonic **"Fentanyl, Nicotine, Scopolamine, Nitroglycerin, Clonidine, Estrogen, Testosterone, and Oxybutynin."** * **Rivastigmine** (for Alzheimer’s) and **Rotigotine** (for Parkinson’s) are other high-yield CNS drugs available as patches. * **Selegiline** is the only MAO inhibitor available as a transdermal patch (used for MDD).

Question 97: Dose-response curves of salbutamol for bronchodilation and tachycardia are widely separated on the dose axis. This information suggests that salbutamol is:

A. A highly potent cardiac stimulant
B. A highly efficacious bronchodilator
C. A highly toxic drug
D. A highly selective drug (Correct Answer)

Explanation: ### Explanation **1. Why Option D is Correct: The Concept of Selectivity** Selectivity refers to the ability of a drug to act on a specific receptor or tissue at a lower dose than that required to produce effects at other sites. In this scenario, the **Dose-Response Curves (DRC)** for bronchodilation (mediated by $\beta_2$ receptors) and tachycardia (mediated by $\beta_1$ and $\beta_2$ receptors in the heart) are "widely separated." This indicates that a therapeutic effect (bronchodilation) is achieved at a much lower dose than the adverse effect (tachycardia). The greater the distance between these two curves on the dose axis, the higher the **selectivity** of the drug for the target tissue. **2. Why Other Options are Incorrect:** * **Option A (Potency):** Potency refers to the amount of drug needed to produce an effect. While Salbutamol is potent, the separation of curves describes *selectivity*, not how much drug is needed in absolute terms. * **Option B (Efficacy):** Efficacy is the maximum response ($E_{max}$) a drug can produce. The horizontal separation of curves relates to the dose (x-axis), not the maximum height of the response (y-axis). * **Option C (Toxicity):** A drug with widely separated curves for therapeutic and toxic effects is actually **safer**, as it possesses a high **Therapeutic Index**. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Selectivity is Dose-Dependent:** At higher doses, selectivity is lost. High doses of Salbutamol (e.g., via nebulization) will eventually cause $\beta_1$ stimulation, leading to tachycardia and tremors. * **Therapeutic Index (TI):** Calculated as $LD_{50} / ED_{50}$. A "widely separated" curve implies a wide TI, making the drug safer. * **Salbutamol vs. Isoprenaline:** Isoprenaline is a non-selective $\beta$-agonist; its curves for bronchodilation and tachycardia would be much closer together compared to Salbutamol.

Question 98: Which of the following antimicrobials needs dose reduction even in mild renal failure?

A. Ciprofloxacin
B. Carbenicillin
C. Cefotaxime
D. Ethambutol (Correct Answer)

Explanation: **Explanation:** The correct answer is **Ethambutol**. **1. Why Ethambutol is correct:** Ethambutol is primarily excreted unchanged by the kidneys (approx. 80%). It has a narrow therapeutic index regarding ocular toxicity (optic neuritis). In renal impairment, the drug accumulates rapidly, significantly increasing the risk of irreversible vision loss. Current guidelines recommend that even in **mild renal failure** (CrCl < 70-100 ml/min), the dose should be monitored, and if CrCl falls below 30 ml/min, the dosing interval must be increased to 3 times weekly rather than daily. **2. Why the other options are incorrect:** * **Ciprofloxacin:** While it is renally excreted, dose reduction is typically only required in **moderate to severe** renal failure (CrCl < 30-50 ml/min). * **Carbenicillin:** This is an antipseudonal penicillin. While it requires adjustment in renal failure to prevent seizures and bleeding diathesis, it has a wider safety margin than ethambutol in mild cases. * **Cefotaxime:** Most cephalosporins have a high therapeutic index. Cefotaxime requires dose adjustment only when the GFR drops below 20 ml/min (**severe** impairment). **3. NEET-PG High-Yield Pearls:** * **Ethambutol Toxicity:** The most characteristic side effect is **retrobulbar neuritis**, resulting in decreased visual acuity and **red-green color blindness**. It is contraindicated in children too young to undergo visual testing. * **Safe in Renal Failure:** Antibiotics like **Ceftriaxone, Doxycycline, Erythromycin, and Rifampicin** are primarily eliminated via the liver/bile and generally do not require dose adjustment in renal failure. * **Rule of Thumb:** Always prioritize dose adjustment for drugs with narrow therapeutic windows (Aminoglycosides, Vancomycin, Ethambutol, Lithium) in renal patients.

Question 99: Acetylsalicylic acid and phenobarbitone are better absorbed from the stomach because they are:

A. Weak acids that remain non-ionic in gastric pH (Correct Answer)
B. Weak acids that remain ionic in gastric pH
C. Strong acids that are fully ionized in gastric pH
D. Weak bases that are ionized at gastric pH

Explanation: ### Explanation **1. Why Option A is Correct: The pH Partition Hypothesis** Drug absorption across biological membranes occurs primarily via **passive diffusion**. For a drug to diffuse through the lipid bilayer of the stomach lining, it must be in its **lipid-soluble, non-ionized (uncharged) form**. According to the Henderson-Hasselbalch equation, **weak acids** (like Aspirin/Acetylsalicylic acid and Phenobarbitone) exist predominantly in their non-ionized form in an acidic environment (low pH). Since the gastric pH is highly acidic (~1–2), these drugs remain uncharged and are readily absorbed through the gastric mucosa. **2. Why the Other Options are Incorrect:** * **Option B:** If weak acids were ionic in the stomach, they would be water-soluble and lipid-insoluble, preventing them from crossing the lipid membrane. * **Option C:** Strong acids (like HCl) are almost completely ionized regardless of pH. High ionization prevents passive diffusion across membranes. * **Option D:** Weak bases (e.g., Atropine, Morphine) become **ionized** (protonated) in acidic environments. This "traps" them in the stomach, preventing absorption until they reach the more alkaline environment of the small intestine. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ion Trapping:** This principle is used to treat toxicity. To accelerate the excretion of a **weak acid** (like Phenobarbitone or Salicylates), we **alkalinize the urine** with Sodium Bicarbonate. This ionizes the drug in the renal tubules, preventing reabsorption and "trapping" it in the urine for excretion. * **Site of Absorption:** Although weak acids are chemically favored for absorption in the stomach, the **small intestine** remains the major site of absorption for *most* drugs (including weak acids) due to its massive surface area (villi/microvilli). * **Pka:** When pH = pKa, 50% of the drug is ionized and 50% is non-ionized.

Question 100: Which of the following drugs binds to albumin?

A. Penicillin (Correct Answer)
B. Lidocaine
C. Propranolol
D. Verapamil

Explanation: **Explanation:** The binding of drugs to plasma proteins is a crucial pharmacokinetic parameter that determines a drug's distribution and half-life. The correct answer is **Penicillin**. **1. Why Penicillin is Correct:** Plasma protein binding is generally determined by the chemical nature of the drug. **Albumin** is the most abundant plasma protein and has a high affinity for **acidic drugs**. Penicillin (along with sulfonamides, salicylates, and warfarin) is an acidic drug and therefore binds primarily to albumin. **2. Why the Other Options are Incorrect:** * **Lidocaine, Propranolol, and Verapamil:** These are all **basic drugs**. Basic drugs do not primarily bind to albumin; instead, they bind to **$\alpha_1$-acid glycoprotein (AAG)** and occasionally to lipoproteins. In states of acute inflammation or stress, AAG levels increase, which can significantly alter the free fraction of these basic drugs. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Acidic-Albumin" Rule:** Remember the mnemonic: **A**cidic drugs bind to **A**lbumin; **B**asic drugs bind to **B**-globulins/$\alpha_1$-acid glycoprotein. * **Displacement Interactions:** Drugs with high albumin binding (e.g., Sulfonamides) can displace other drugs like Bilirubin in neonates, leading to **Kernicterus**, or displace Warfarin, leading to increased bleeding risk. * **Pharmacologically Active Form:** Only the **unbound (free) fraction** of a drug is pharmacologically active, metabolized, and excreted. * **Hypoalbuminemia:** In conditions like Nephrotic syndrome or Cirrhosis, decreased albumin leads to an increase in the free fraction of acidic drugs, potentially causing toxicity even at "normal" doses.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free